Pharma Pulse 7/25/24: Driving CAR-Ts for Treatment in Cancer and Immunology, CrowdStrike Explains What Went Wrong in Global Outage & more
The latest news for pharma industry insiders.
Driving CAR-Ts for Treatment in Cancer and Immunology
A deep dive into why this therapy has demonstrated effectiveness in various areas, including for tumors.
Ongoing Stigma Remains a Major Obstacle in the Fight Against HIV | AIDS 2024
At the 25th annual international AIDS Conference in Munich, Germany, a group of international experts discussed the impact of HIV-related stigma and discrimination on efforts to end the HIV pandemic as a public health threat by 2030.
CrowdStrike Explains What Went Wrong Days After Global Tech Outage
Cybersecurity company lays out steps to prevent future quality-control disruptions.
Giroctocogene fitelparvovec study meets primary and key secondary objectives of superiority compared to prophylaxis.
Great insights by Abid Rahman from EVERSANA on the power of #AIas it revolutionizes operations across many industries, including #pharma. Always great to see a publication like Pharmaceutical Executive want to connect with experts.
Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Asembia 2025: Therapy Advancements Highlight Growing Cost and Access Concerns
April 30th 2025Fran Gregory, VP, emerging therapies, Cardinal Health, discusses the evolving cell and gene therapy landscape, highlighting pipeline growth, cost challenges, and emerging therapeutic areas beyond oncology and hematology.
